logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Chronic Obstructive Pulmonary Disease

    FiltersReset Filters
    13 results

    • acetylcysteine

      (Acetylcysteine)
      Somerset Therapeutics, LLC
      Usage: Acetylcysteine solution, USP is indicated as adjuvant therapy for abnormal mucous secretions in chronic and acute bronchopulmonary diseases, pulmonary complications of cystic fibrosis, tracheostomy care, surgical pulmonary complications, anesthetic use, post-traumatic chest conditions, atelectasis due to mucous obstruction, and diagnostic bronchial studies.

    • arformoterol tartrate

      (Arformoterol Tartrate)
      Sun Pharmaceutical Industries, Inc.
      Usage: Arformoterol tartrate inhalation solution is indicated for long-term maintenance treatment of bronchoconstriction in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, administered via nebulization. It is not for acute COPD exacerbations or for treating asthma.

    • arformoterol tartrate

      (Arformoterol Tartrate)
      Ingenus Pharmaceuticals, LLC
      Usage: Arformoterol tartrate inhalation solution is indicated for the long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD). It is not intended for acute exacerbations or for asthma treatment. Administration is via nebulization, twice daily.

    • formoterol fumarate

      (Formoterol fumarate)
      Micro Labs Limited
      Usage: Formoterol fumarate inhalation solution is indicated for the long-term maintenance treatment of bronchoconstriction in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is not intended for acute COPD exacerbations or asthma treatment, and its safety for asthma has not been established.

    • formoterol fumarate

      (Formoterol Fumarate)
      Ingenus Pharmaceuticals, LLC
      Usage: Formoterol fumarate inhalation solution is indicated for the long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is not meant for acute COPD exacerbations or for asthma treatment.

    • formoterol fumarate

      (formoterol fumarate)
      Dr. Reddy's Laboratories Inc.
      Usage: Formoterol Fumarate Inhalation Solution is indicated for the long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD). It is not intended for treating acute COPD exacerbations or asthma.

    • formoterol fumarate inhalation solution

      (formoterol fumarate dihydrate)
      Ritedose Pharmaceuticals, LLC
      Usage: Formoterol Fumarate Inhalation Solution is indicated for long-term maintenance treatment of bronchoconstriction in chronic obstructive pulmonary disease (COPD) patients, taken twice daily. It is not intended for acute COPD exacerbations or for treating asthma, as its safety and effectiveness in asthma are not established.

    • formoterol fumarate inhalation solution and pari lc plus nebulizer

      (Formoterol Fumarate Inhalation Solution and PARI LC PLUS Nebulizer)
      Genericus, Inc.
      Usage: Formoterol fumarate inhalation solution is indicated for the long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is not intended for acute COPD exacerbations or asthma treatment.

    • ipratropium bromide

      (Ipratropium Bromide)
      Ritedose Pharmaceuticals, LLC
      Usage: Ipratropium Bromide Inhalation Solution is indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, and can be used alone or with other bronchodilators, particularly beta-adrenergics.

    • prednisolone sodium phosphate

      (Prednisolone Sodium Phosphate)
      PAI Holdings, LLC
      Usage: Prednisolone sodium phosphate oral solution is indicated for severe allergic conditions, dermatologic and endocrine disorders, gastrointestinal diseases, hematologic disorders, neoplastic diseases, acute multiple sclerosis exacerbations, ocular inflammation, respiratory diseases, rheumatic disorders, and specific miscellaneous conditions involving tuberculosis and organ rejection.